Continuous infusion versus intermittent administration of meropenem in critically ill patients
Florian Thalhammer, Heinz Burgmann(Medical University of Vienna), Ibrahim El Menyawi(Office of Infectious Diseases), Thomas Staudinger(Northwestern University), Brigitte Stoiser(Austrian Atherosclerosis Society), Friederike Traunmüller(Office of Infectious Diseases), Ursula Hollenstein(Office of Infectious Diseases), Renate Thalhammer-Scherrer(University of Vienna), Gottfried J. Locker(Austrian Atherosclerosis Society), Michael Frass(Medical University of Vienna)
Cited by 126
Related Papers
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
|The Lancet Infectious Diseases|2013|876
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
|The Lancet Respiratory Medicine|2014|648
Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDS
|Intensive Care Medicine|2013|603
Symptoms of burnout in intensive care unit specialists facing the COVID-19 outbreak
|Annals of Intensive Care|2020|392
Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
|Critical Care Medicine|2000|344